您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (2): 22-26.doi: 10.6040/j.issn.1671-7554.0.2021.1148

• 临床医学 • 上一篇    下一篇

脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达

宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华   

  1. 山东大学生殖医学研究中心(山东大学附属生殖医院)生殖内分泌教育部重点实验室 山东省生殖医学重点实验室山东省生殖健康临床医学研究中心 国家辅助生殖与优生工程技术研究中心, 山东 济南 250012
  • 发布日期:2022-01-25
  • 通讯作者: 石玉华. E-mail:shiyuhua2003@126.com
  • 基金资助:
    国家重点研发计划(2018YFC1003202,2017YFC1001004);泰山学者工程专项经费(ts201712103)

Expression of fatty acid transport protein 1 in granulosa cells of patients with polycystic ovary syndrome

SONG Tian, FU Linlin, WANG Qiumin, YANG Xiao, WANG Ying, BIAN Yuehong, SHI Yuhua   

  1. Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University;
    Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University;
    Shandong Key Laboratory of Reproductive Medicine;
    Shandong Provincial Clinical Research Center for Reproductive Health;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Jinan 250012, Shandong, China
  • Published:2022-01-25

摘要: 目的 探讨脂肪酸转运蛋白1(FATP1)在多囊卵巢综合征(PCOS)患者颗粒细胞中的表达水平及临床意义。 方法 选取进行体外受精-胚胎移植(IVF-ET)的75例PCOS患者(PCOS组),根据体质量指数(BMI)≥25判定为肥胖的标准,分为PCOS正常体质量组(n=36)和PCOS肥胖组(n=39);同期62例因输卵管梗阻或男方因素助孕患者(对照组),分为对照正常体质量组(n=31)和对照肥胖组(n=31)。采用逆转录实时定量PCR(qRT-PCR)检测患者颗粒细胞中FATP1的表达,分析其在PCOS患者中的差异性表达。 结果 FATP1在PCOS组卵巢颗粒细胞中的表达高于对照组(P <0.001);FATP1在PCOS正常体质量组卵巢颗粒细胞中的表达高于对照正常体质量组(P<0.001); FATP1在PCOS肥胖组卵巢颗粒细胞中的表达高于对照肥胖组(P<0.001)。二分类Logistic回归分析结果显示,高FATP1表达水平(OR=4.242, 95%CI:2.025~8.883, P<0.001)、高抗苗勒氏管激素(AMH,OR=1.512, 95%CI:1.184~1.928, P<0.001)水平、 高黄体生成素/卵泡刺激素(LH/FSH,OR=4.301, 95%CI:1.265~15.304, P=0.02)比值和高睾酮(T,OR=1.059, 95%CI:1.003~1.117, P=0.038)水平是影响PCOS的危险因素。 结论 FATP1在PCOS患者颗粒细胞中表达增高,可能在PCOS发生发展中发挥重要作用。

关键词: 脂肪酸转运蛋白1, 多囊卵巢综合征, 颗粒细胞, 脂肪酸, 增殖

Abstract: Objective To investigate the expression of fatty acid transport protein 1(FATP1)in granulosa cells of patients with polycystic ovary syndrome(PCOS)and its clinical significance. Methods A total of 75 PCOS patients(PCOS group)undergoing in vitro fertilization-embryo transform(IVF-ET)were selected. According to the standard of body mass index(BMI)≥ 25 as obesity, the subjects were divided into normal BMI PCOS group(n=36)and obese PCOS group(n=39). Another 62 patients(control group)seeking assisted reproduction treatment due to tubal or male factors were divided into normal BMI control group(n=31)and obese control group(n=31). The expression of FATP1 in patients granulosa cells was detected with reverse transcription real-time quantitative PCR(qRT-PCR), and its differential expression in PCOS patients was analyzed. Results The expression of FATP1 was higher in PCOS group than in controls(P<0.001), higher in the normal BMI PCOS group than in normal BMI control group(P<0.001), and higher in obese PCOS group than in obese control group(P<0.001). Binary Logistic regression analysis showed that higher FATP1 level(OR=4.242, 95%CI: 2.025-8.883, P<0.001), higher anti-Mullerian hormone level(AMH, OR=1.512, 95%CI: 1.186-1.928, P<0.001), higher luteotropic hormone/follicle stimulating hormone ratio(LH/FSH, OR=4.401, 95%CI: 1.265-15.304, P=0.02), and higher testosterone level(T, OR=1.059, 95%CI: 1.003-1.117, P=0.038)were risk factors of PCOS. Conclusion The expression of FATP1 is increased in PCOS patients, suggesting that FATP1 may play an important role in the development of PCOS.

Key words: Fatty acid transport protein1, Polycystic ovary syndrome, Granulosa cells, Fatty acid, Proliferation

中图分类号: 

  • R711.75
[1] Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome [J]. Nat Rev Dis Primers, 2016, 2: 16057. doi: 10.1038/nrdp.2016.57.
[2] Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome—challenges and opportunities for treatment [J]. Nat Rev Endocrinol, 2021, 17(9): 521-533.
[3] Wekker V, Dammen Lvan, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis [J]. Hum Reprod Update, 2020, 26(6): 942-960.
[4] Li M, Zhao H, Zhao SG, et al. The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome [J]. J Clin Endocrinol Metab, 2019, 104(4): 1049-1059.
[5] Mallick R, Basak S, Duttaroy AK. Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers [J]. Prog Lipid Res, 2021, 83: 101116. doi: 10.1016/j.plipres.2021.101116.
[6] Huang J, Zhu R, Shi D. The role of FATP1 in lipid accumulation: a review [J]. Mol Cell Biochem, 2021, 476(4): 1897-1903.
[7] Lopes-Coelho F, André S, Félix A, et al. Breast cancer metabolic cross-talk: fibroblasts are hubs and breast cancer cells are gatherers of lipids [J]. Mol Cell Endocrinol, 2018, 462(Pt B): 93-106.
[8] Zhang M, Di Martino JS, Bowman RL, et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins [J]. Cancer Discov, 2018, 8(8): 1006-1025.
[9] Cai M, Wang H, Li JJ, et al. The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise [J]. Brain Behav Immun, 2016, 57: 347-359. doi: 10.1016/j.bbi.2016.05.010.
[10] Cao Y, Chang S, Dong J, et al. Emodin ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle [J]. Eur J Pharmacol, 2016, 780: 194-201. doi: 10.1016/j.ejphar.2016.03.049.
[11] Caballero B. Humans against obesity: who will win[J]. Adv Nutr, 2019, 10(suppl 1):S4-S9.
[12] 贺婷婷, 刘昕, 刘洪彬, 等. 多囊卵巢综合征患者颗粒细胞叉头框蛋白O1 mRNA的表达与意义[J]. 山东大学学报(医学版), 2019, 57(2): 75-79. HE Tingting, LIU Xin, LIU Hongbin, et al. Expression of Forkhead box protein O1 mRNA in granulosa cells of polycystic ovary sydrome patients and its significance [J]. Journal of Shandong University(Health Sciences), 2019, 57(2): 75-79.
[13] 贺婷婷, 刘红, 舒凯云, 等. 多囊卵巢综合征患者颗粒细胞中 microRNA-141的表达与意义[J]. 山东大学学报(医学版), 2019, 57(5):116-120. HE Tingting, LIU Hong, SHU Kaiyun, et al. Expression and significance of microRNA-141 in granulosa cells inpatients with polycystic ovary syndrome [J]. Journal of Shandong University(Health Sciences), 2019, 57(5): 116-120.
[14] Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment [J]. J Clin Endocrinol Metab, 2021,106(3): e1071-e1083.
[15] Leung KL, Sanchita S, Pham CT, et al. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome(PCOS)women during adipogenesis: evidence of cellular programming [J]. Clin Epigenetics, 2020,12(1): 181. doi: 10.1186/s13148-020-00970-x.
[16] Valckx SD, Arias-Alvarez M, De Pauw I, et al. Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study [J]. Reprod Biol Endocrinol, 2014, 12: 13. doi: 10.1186/1477-7827-12-13.
[17] Maillard V, Desmarchais A, Durcin M, et al. Docosahexaenoic acid(DHA)effects on proliferation and steroidogenesis of bovine granulosa cells[J]. Reprod Biol Endocrinol, 2018, 16(1): 40. doi: 10.1186/s12958-018-0357-7.
[18] Zhou S, Xia L, Chen Y,et al. miR-3188 regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome[J]. Acta Biochim Pol, 2021, 68(1): 83-89.
[19] Bao D, Li M, Zhou D, et al. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4 [J]. J Steroid Biochem Mol Biol, 2021, 209: 105844. doi: 10.1016/j.jsbmb.2021.105844.
[20] Mendes C, Lopes-Coelho F, Ramos C, et al. Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy [J]. Sci Rep, 2019, 9(1): 14107. doi: 10.1038/s41598-019-50531-3.
[21] Xu XL, Deng SL, Lian ZX, et al. Estrogen receptors in polycystic ovary syndrome [J]. Cells, 2021,10(2): 459. doi: 10.3390/cells10020459.
[22] Lee EB, Chakravarthi VP, Wolfe MW, et al. ERβ regulation of gonadotropin responses during folliculogenesis [J]. Int J Mol Sci, 2021, 22(19):10348. doi: 10.3390/ijms221910348.
[23] Meroni M, Dongiovanni P, Longo M, et al. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes [J]. EBioMedicine, 2020, 52: 102658. doi: 10.1016/j.ebiom.2020.102658.
[24] Ye G, Gao H, Wang Z, et al. PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression [J]. Cell Death Dis, 2019, 10(2): 39. doi: 10.1038/s41419-018-1135-3.
[25] Nishiyama K, Fujita T, Fujimoto Y, et al. Fatty acid transport protein 1 enhances the macrophage inflammatory response by coupling with ceramide and c-Jun N-terminal kinase signaling [J]. Int Immunopharmacol, 2018, 55: 205-215. doi: 10.1016/j.intimp.2017.12.003.
[26] Hipólito A, Martins F, Mendes C, et al. Molecular and metabolic reprogramming: pulling the strings toward tumor metastasis [J]. Front Oncol, 2021, 11: 656851. doi: 10.3389/fonc.2021.656851.
[1] 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[2] 殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73.
[3] 韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[4] 万文静,高姗姗. 低分子肝素在生殖领域的应用[J]. 山东大学学报 (医学版), 2025, 63(6): 117-124.
[5] 王刚,徐鹏演,赵旭安,王海锋,葛苗苗,潘华峰,江志伟. ω-3多不饱和脂肪酸对腹腔镜结直肠癌术后迷走神经和肠功能恢复的影响[J]. 山东大学学报 (医学版), 2025, 63(2): 36-42.
[6] 李观强,施昱诚,朱可涵,胡波,黄献琛,孙元,李笃信,张喜成. 蜗牛粘液来源的活性肽SK-14促进成纤维细胞的增殖和迁移[J]. 山东大学学报 (医学版), 2025, 63(11): 1-7.
[7] 杜煜晗,孙莹,杜惠兰. 红花如意丸对寒凝血瘀型子宫内膜异位症痛经患者疼痛的疗效及机制[J]. 山东大学学报 (医学版), 2025, 63(10): 52-60.
[8] 张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42.
[9] 刘向荣,张新胜,杨荩冉,杨雪艳,刘钊,刘英华. ω-6/ω-3多不饱和脂肪酸比值对不同肿瘤发病风险的系统综述和Meta分析[J]. 山东大学学报 (医学版), 2024, 62(8): 34-48.
[10] 曹华琳,贾彦召,曲莉,尹昕. CircFAT1调节miR-296-3p/MAPRE1轴对鼻咽癌细胞增殖、凋亡和放疗敏感性的影响[J]. 山东大学学报 (医学版), 2023, 61(9): 38-46.
[11] 金珊,高杰,谢玉姣,展垚,杜甜甜,王传新. 甲基转移酶PRMT5稳定USP15促进乳腺癌发生发展的作用[J]. 山东大学学报 (医学版), 2023, 61(7): 1-11.
[12] 何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10.
[13] 赵元元,路军涛,吴小华. 人脐带间充质干细胞外泌体miR-100对多囊卵巢综合征患者颗粒细胞炎症的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 51-58.
[14] 董相君,李娟,孔雪,李培龙,赵文静,梁怡然,王丽丽,杜鲁涛,王传新. 环状RNA hsa_circ_0008591对乳腺癌细胞生物学行为的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 78-87.
[15] 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!